Third stage of DIC syndrome: hypocoagulation phase
The third stage of DIC syndrome in pathophysiology is classified as the hypocoagulation stage. This is a critical stage of the pathological process, characterized by a complete failure of the body's compensatory mechanisms in the field of hemostasis. The body loses the ability to form full-fledged blood clots to stop blood loss.
The development of this stage is based on the following key mechanisms, which must be clearly understood:
- Exhaustion of coagulation and anticoagulation mechanisms. This is the absolute central link of the pathogenesis. Coagulation factors have been actively consumed previously, and now their plasma reserve is critically reduced.
- Thrombocytopenia. This term refers to a sharp drop in the count of circulating blood platelets. Without a sufficient platelet pool, adequate hemostasis becomes impossible.
- Activation of fibrinolysis. The process of dissolving fibrin clots enters a hyperactive, pathological phase, destroying the newly formed thrombi.
- Vitamin K deficiency. Acts as a potent additional factor exacerbating the severity of coagulopathy.
A natural and most formidable clinical consequence of all these processes is generalized bleeding. The blood loses its ability to clot, leading to massive blood loss that poses an immediate threat to the patient's life.
Principles of complex therapy for DIC syndrome
The management of patients with the full-blown clinical picture of DIC syndrome represents a most complex challenge for the clinician. Therapy must under no circumstances be unidirectional; it must be strictly comprehensive in nature. In modern clinical practice, several fundamental approaches to managing such patients are distinguished:
- Etiotropic approach. Aimed at identifying and immediately eliminating the root cause that originally triggered the pathological cascade of intravascular coagulation.
- Pathogenetic approach. Implies targeted intervention in the mechanisms of syndrome development to break the vicious circle of coagulopathy.
- Replacement approach. The patient vitally needs external replenishment of critically lost blood components and coagulation factors.
- Symptomatic approach. Focuses on maintaining the body's baseline vital functions and alleviating individual manifestations of the disease.
- Palliative approach. Used in situations where radical cure of the underlying disease is no longer possible, with the aim of minimizing the patient's suffering.
The role of symptomatic therapy
A special place in the management of severe conditions is occupied by symptomatic therapy. Its main goal is to maximize the relief of the patient's condition against the background of the unfolding clinical picture.
The main areas of symptomatic care are strictly regulated and include the following aspects:
- Relief of distressing sensations. First and foremost, this concerns the relief of pronounced pain syndromes that exhaust the patient. In addition, a crucial task is the adequate correction of psycho-emotional stress and other uncomfortable manifestations.
- Correction of functional insufficiency. The physician must promptly respond to malfunctions in the work of organs and physiological systems, supporting their functioning at a viable level through medical or hardware support.
Hemoblastoses as a comorbid pathology
In the context of studying mortality causes in diseases of the hematopoietic system, it is necessary to examine hemoblastoses in detail. Hemoblastosis is a malignant neoplasm whose primary substrate consists of mutated hematopoietic cells.
From an epidemiological perspective, these neoplastic diseases pose a colossal danger. According to statistical data, hemoblastoses confidently occupy the first place as a cause of death among absolutely all known diseases of the hematopoietic system.
Causes of hemoblastosis development are fundamentally similar to the etiological factors causing the growth of any other malignant tumors. Pathophysiology distinguishes three main groups of carcinogens capable of provoking a mutation:
- Physical carcinogens.
- Chemical carcinogens.
- Biological carcinogens.
Briefly: answers to topical questions
What laboratory parameters are characteristic of the hypocoagulation stage of DIC syndrome?
Laboratory parameters during the hypocoagulation stage reflect the intensive consumption of coagulation factors and the activation of fibrinolysis.
Clinical and laboratory manifestations include:
- Hypofibrinogenemia — a decrease in blood fibrinogen levels.
- Thrombocytopenia — a significant decrease in platelet count due to their increasing consumption.
- Decreased antithrombin — a drop in its concentration in the blood.
- Elevated FDPs — an increase in the level of fibrin degradation products in the blood, which is a marker of active fibrinolysis.
For quick memorization of approaches to DIC therapy, use the acronym PES-SP: Pathogenetic, Etiotropic, Substitution (Replacement), Symptomatic, Palliative.
Class and exam questions
Which stage of DIC syndrome is the third one?
The third stage of DIC syndrome in pathophysiology is called the hypocoagulation stage.
What is the basis for the development of the hypocoagulation stage?
It is based on the critical exhaustion of coagulation and anticoagulation mechanisms, as well as thrombocytopenia, activation of fibrinolysis, and vitamin K deficiency.
What does the exhaustion of coagulation factors lead to in Stage III?
This pathological condition inevitably leads to the development of massive generalized bleeding.
What place do hemoblastoses occupy in the mortality structure?
Hemoblastoses (neoplasms from hematopoietic cells) rank first as a cause of death among all diseases of the hematopoietic system.
What else to study on this topic
- Mechanisms of depletion of coagulation and anticoagulation systems
- The role of thrombocytopenia and vitamin K deficiency in the pathogenesis of bleeding
- The process of fibrinolysis activation in DIC syndrome
- Etiotropic and pathogenetic approaches in the treatment of coagulopathies
- Classification of physical, chemical, and biological carcinogens in hemoblastoses
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Stages of DIC Syndrome" and 4,913 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 135 video lessons on the subject
Other topics in "Chapter 21. Typical Pathology Forms of the Blood System"
Free video lessons: pathophysiologyShort lessons with lecture notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.